TP53 and neoplasm: The loss of function of tumor repressor genes p53 and/or CDKN2A contributes to the induction and/or over-expression of various extracellular matrix-degrading enzymes including MMPs and urokinase, leading to increased tumor cells invasiveness [6], [8]–[12].